Panacea Journal of Medical Sciences
  • Year: 2015
  • Volume: 5
  • Issue: 3

Menopause and the metabolic syndrome

  • Author:
  • Almeida Joylene
  • Total Page Count: 3
  • Page Number: 158 to 160

Assistant Professor, Consultant obstetrician and gynaecologist, Father Muller Medical College Hospital, Mangalore. joylene16@yahoo.com

Online published on 3 February, 2016.

Abstract

Menopause is the period in a woman's life when she is undergoing hormonal and metabolic changes. Metabolic syndrome or syndrome X comprises of a set of cardiovascular risk factors: obesity, elevated blood pressure, hyperglycemia or insulin resistance and dyslipidemia. Menopause is the point in the timeline of a woman where she is exposed to risk factors for cardiac ill health. The preferential central pattern of fat deposition in obese post-menopausal women is associated with a higher risk of diabetes, hypertriglyceridemia, hypertension and cardiac disease. Hormone therapy improves the altered lipid profile in women with metabolic syndrome and these effects are more pronounced in post-menopausal women. It is important to have more efforts for regular lipid screening and educational programs for a healthy life style for an obese post-menopausal woman.

Keywords

Metabolic syndrome, Menopause, Hormone therapy